SCHEMBL4485273

SCHEMBL4485273

c1csc(Cc2ccc3ccccc3c2Oc2c(Cc3cccs3)ccc3ccccc23)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ HPGD P15428 4/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ TSHR P16473 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ CASP3 P42574 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9614828 0.79 — —
SCHEMBL6755235 0.78 HPGD (0.55) ALDH1A1SMN1; SMN2HPGDKDM4ELMNA
SCHEMBL340868 0.75 GPR55 (0.46) —
SCHEMBL30505689 0.71 CYP2C9 (0.50) SMN1; SMN2HPGDKDM4ELMNAMEN1
SCHEMBL21490412 0.71 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2HPGDKDM4ELMNA
SCHEMBL3041845 0.71 HPGD (0.53) ALDH1A1SMN1; SMN2HPGDKDM4ELMNA
SCHEMBL8763678 0.71 SLC2A1 (0.44) ALDH1A1TSHR
SCHEMBL11716781 0.71 CYP2A6 (0.42) ALDH1A1L3MBTL1TSHR
SCHEMBL11859580 0.71 HSD17B10 (0.42) ALDH1A1TSHRCYP2C9
SCHEMBL6755241 0.70 HSD17B10 (0.66) ALDH1A1SMN1; SMN2HPGDKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550605-B2 Process for preparation of an anitdepressant compound SUN PHARMACEUTICAL INDUSTRIES LTD. (IN) 2009-06-23 — — US disclosed
US-20070191616-A1 Process for preparation of an antidepressant compound SUN PHAMACEUUTICAL INDUSTRIES LTD. (IN) 2007-08-16 — — US disclosed
WO-2006027798-A2 A PROCESS FOR PREPARATION OF AN ANTIDEPRESSANT COMPOUND SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2006-03-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191616-A1 Process for preparation of an antidepressant compound TPH1, TPH2, HTR4 ALDH1A1 359/4885SMN1; SMN2 1243/4885HPGD 1866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback